American Vietnamese Biotech (HSTC:AMV) Total Debt per Share: ₫0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Vietnamese Biotech Total Debt per Share?

American Vietnamese Biotech HSTC:AMV Total Debt per Share is ₫0.00 as of . 20.

₫0.00 (As of . 20)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. American Vietnamese Biotech's Total Debt Per Share for the quarter that ended in . 20 was ₫0.00.

American Vietnamese Biotech Total Debt per Share Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Total Debt per Share Chart

American Vietnamese Biotech Annual Data
Trend
Total Debt per Share

American Vietnamese Biotech Quarterly Data
Total Debt per Share

American Vietnamese Biotech Total Debt per Share Calculation

American Vietnamese Biotech's Total Debt Per Share for the fiscal year that ended in . 20 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

American Vietnamese Biotech's Total Debt Per Share for the quarter that ended in . 20 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of ₫0.00 mean?
American Vietnamese Biotech (HSTC:AMV) has a Total Debt per Share of ₫0.00 as of . 20. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Total Debt per Share too high?
American Vietnamese Biotech's current Total Debt per Share is ₫0.00.
How does American Vietnamese Biotech's Total Debt per Share compare to HSTC and STLT?
American Vietnamese Biotech's Total Debt per Share of ₫0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Total Debt per Share is ₫0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Total Debt per Share of ₫0.00. The current Total Debt per Share is ₫0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Total Debt per Share is ₫0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.